A. McEvoy

A. McEvoy

EVP, Worldwide Chair MedTechatJohnson & Johnson· In proxies 2022–2023

Pay in FY2023+27% from the year before

A. McEvoy was paid $9.4M in FY2023 (Dec), up 27%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Johnson & Johnson proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Johnson & JohnsonPublic company · 4 yr
    • EVP, Worldwide Chair MedTech2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?